2021-03-31-accounts - Multiple System Atrophy Trust

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

					Pages
Report ofthe Chair					2-3
Report ofthe Trustees					4-14
Independent Auditor's	Report				15-20
Statement of Financial	Activities	(including	the Income and Expenditure	account)	21
Balance Sheet					22-23
Statement ofCash Flows					24
Notes to the Financial	Statements				25-36

AR ENDED 31MARCH 2	021
			Unrestricted	Restricted	Total funds	Total funds
		Note	Income Fund	Income	2021	2020
				Fund
Income and endowments	from:
Donations and legacies			514,023	205,819	719,842	738,879
Activities for generating	funds		139,360		139,360	197,532
Investments			1,318		1,318	7,754
Other			43,075		43,075
Total income and endowments			697,776	205,819	903,595	944,165
Expenditure on:
Raising funds		8	188,482		188,482	209,398
Charitable activities		8	271,706	267,061	538,767	997,084
Total expenditure		8	460,188	267,061	727,249	1,206,482
Net gains/(losses) on investments			252,627		252,627	(2,397)
Net income/(expenditure)			490,215	(61,242)	428,973	(264,714)
Transfers between funds
Net movement in funds			490,215	(61,242)	428,973	(264,714)
Reconciliation offunds:
Total Funds at 31March	2020		1,373,476	305,952	1,679,428	1,944,142
Total funds at 31March	2021		1,863,691	244,710	2,108,401	1,679,428

LANCE SHEE 31MARCH	T 2021					Company	number: 07	302036
					Unrestricted	Restricted	Total	Total
				Note	Income	income	funds	funds
					Fund	Fund	2021	2020
Fixed assets
Tangible assets				12	10,244		10,244	9,999
Investments				13	1,431,717	896,679	2,328,396	2,074,556
					1,441,961	896,679	2,338,640	2,084,555
Current assets
Stocks				14	7,570		7,570	8,228
Debtors				15	243,209		243,209	197,351
Cash at bank	and in	hand		16	191,470		191,470	221,710
					442 249		442 249	427 289
Liabilities:
Creditors: Amounts		falling due within one		17	(20,519)	(421,998)	(442,517)	(337,418)
year
Net current	assets/(liabilities)				421,730	(421,998)	(268)	89,871
Total assets	less current		liabilities		1,863,691	474,681	2,338,372	2,174,426
Creditors: Amounts		falling due after more		18		(229,971)	(229,971)	(494,998)
than one year
Net assets/(liabilities)					1,863,691	244,710	2,108,401	1,679,428
Charity Funds
Unrestricted	funds				1,609,851		1,609,851	1,228,622
Revaluation	reserve				253,840		253,840	144,854
Restricted funds				23		244,710	244,710	305,952
Total charity	funds				1,863,691	244,710	2,108,401	1,679,428

AR ENDED 31MARCH 20	21
				Total funds	Total funds
			Note	2021	2020
				E	E
Cash flow from operating	activities		19	(26,612)	(68,452)
Cash flow from investing	activities
interest received				1,318	7,754
Payments to acquire oftangible fixed assets				(3,777)	(2,364)
Receipts from sales oftangible assets				44
Payments to acquire investments				(301,213)	(232,543)
Receipts from sale of investments				300,000	375,000
Net cash flow from investing activities				(3,628)	147,847
Change in cash and cash	equivalents			(30,240)	79,395
Cash and cash equivalents	brought	forward		221,710	142,315
Cash and cash equivalents	carried	forward		191,470	221,710
Cash and cash equivalents	consist	of:
Cash at bank and in hand				191,470	221,710
Short term deposits
Cash and cash equivalents	at 31March 2021			191,470	221,710

useful economic life as f	ollows:	ollows:
Asset class	Depreciation		method and rate
Office equipment	Straight	line	over 5years
Patient aids	Straight	line	over 5years

Income	from donations and legacies
		Unrestricted	Restricted	Total	Total
		Income	Income	2021	2020
		Fund	Fund
		E	E	f	E
Donations	and legacies
Donations	under the Gift Aid scheme	60,389		60,389	39,103
Legacy donations		55,261		55,261	186,546
Memoriam	donations	143,210	27,395	170,605	121,873
Other donations		255,163	178,424	433,587	391,357
		514,023	205,819	719,842	738,879

Income from activities for ge	nerating funds
	Unrestricted	Restricted	Total	Total
	Income	Income	2021	2020
	Fund	Fund
	E	E	E	E
Event income	127,186		127,186	182,028
Merchandise	12,174		12,174	15,504
	139,360		139,360	197,532

						Unrestricted	Restricted	Total	Total
						Income	Income	2021	2020
						Fund	Fund
						E	E	E	E
Interest	receivable	from	UK	deposit	account	1,318		1,318	7,754
						1,318		1,318	7,754

			Unrestricted	Restricted	Total	Total
			Income	Income	2021	2020
			Fund	Fund
					E	E
)ob	retention	scheme	43,075		43,075
			43,075		43,075

Net inco	me/(	expenditure) and n	et movements in funds have	been stated after charging:
				Total	Total
				2021	2020
				E	E
Depreciation	of	tangible fixed assets		3,488	2,918
(Profit)/loss	on	fair value movement	ofinvestments	(252,627)	2,397

Analysis ofreso	urces expended
		Total	Total
		2021	2020
Cost ofgenerating	funds
Merchandise		3,822	1,570
Events and catering		1,673	6,184
Salaries		96,248	88,591
PR and Marketing		3,912	4,337
Support costs		82,826	108,716
		188,482	209,398

tricted fun	ds was 6 nil (2020 —6 nil).
		Direct	Support	Total	Total
		activities	costs	2021	2020
			E	E	f
Charitable	activities
Research		106,669	13,177	119,846	568,815
Info and patient support		326,684	92,237	418,921	428,269
		433,353	105,414	538,767	997,084

			Cost of	Research	Info and	Total
			generating		patient
			funds		support
					f
Bookkeeping	and administration	fees	1,641	261	1,827	3,729
Rent			13,255	2,109	14,762	30,126
Office costs			41,140	6,545	45,814	93,499
Sundry			524	83	584	1,191
Governance	costs (see note 9)		26,266	4,179	29,250	59,695
			82,826	13,177	92,237	188,240

			Total	Total
			2021	2020
			E	E
Auditor's	remuneration		3,888	3,744
Accountancy		fees	2,932	5,869
Professional		fees	25,385	32,288
Salaries			27,480	28,455
Trustees'	meetings		10	263
			59,695	70,619

			Grants to	Direct	Support	Total
			Institutions	costs	costs
			E	E
Dr	V	Chelban	64,322			64,322
			64,322			64,322

e average number of pe	rsons employed by the charity during	the year was:
		Total	Total
		2021	2020
Office staff
Specialist nurses
Advocacy Officer/Social	Welfare Specialist
		13

. Staff costs (continued)
	Total	Total
	2021	2020
	E	E
Gross wages	410,979	392,558
Social security	34,480	34,353
Pension costs	18,321	19,318
	463,780	446,229

12.Tangible	fixed assets	Office	Patient	Total
		equipment	Aids
Cost or valuation
At April 2020		19,277	57,577	76,854
Additions		3,777		3,777
Disposals		(289)		(289)
At 31March	2021	22,765	57,577	80,342
Depreciation
At April 2020		14,833	52,022	66,855
Charge for the year		1,778	1,710	3,488
Elimination	on disposal	(245)		(245)
At 31March	2021	16,366	53,732	70,098
Net BookValue
At 31March	2021	6,399	3,845	10,244
At 31March	2020	4,444	5,555	9,999

13.Investments	13.Investments			Total
				2021
Cost or valuation				E
At 1April 2020				2,074,556
Additions				301,213
Disposals				(300,000)
Revaluation				252,627
At 31March	2021			2,328,396
Impairment
At 1April 2020 and		31March 2021
Carrying amount
At 31March	2021			2,328,396
At 31March	2020			2,074;556
					Market
				Cost	Value
				31March	31March
				2021	2021
The Trustees'	investments		were made up as	f	E
follows:
CCLA				1,986,180	2,328,396
				1,986,180	2,328,396
				31March	31March
				2021	2020
Investments	at fair value		comprise:	E	E
Equities				1,009,918	1,057,291
Cash with investment		portfolio		1,318,478	1,017,265
				2,328,396	2,074,556

14.Stock
					2021	2020
Finished goods:	Merchandise				7,570	8,228
15.Debtors
					2021	2020
					f	E
Trade debtors
Other debtors					44,993	24,684
Accrued income					198,216	172,667
					243,209	197,351
16.Cash at bank
			Unrestricted	Restricted	Total	Total
			income	income	funds	funds
			funds	funds	2021	2020
				E	E
Cash committed	for	research grant funding
Other cash			191,470		191,470	221,710
			191,470		191,470	221,710
17.Creditors: amounts		falling due within one year
					2021	2020
					E	E
Accrual for Research		grants			421,998	313,427
Other taxation	and social security				10,159	9,321
Other creditors					10,360	14,670
					442,517	337,418

2021	2020
E	E
229,971	494,998

. Reconciliat	ion o	f net move	ment in funds to net cash flo	w from operating activities
				Total	Total
				funds	funds
				2021	2020
				E	E
Movement in	net funds			428,973	(264,714)
Depreciation	oftangible fixed		assets	3,488	2,918
Interest receivable				(1,318)	(7,754)
(Gains)/losses	on investments			(252,627)	2,397
Decrease/(Increase)		in stocks		658	(5 157)
Decrease/(Increase)		in debtors		(45,858)	(41,398)
Increase/(Decrease)		in creditors		(159,928)	245,256
Net cash flow	from	operating	activities	(26,612)	(68,452)

			Total	Total
			funds	funds
			2021	2020
Within	one	year	2,404	5,019
Within	one	to five years	7,724	10,129
			10,128	15,148

			Research	Nurse	Regional	Other	Total	Total
				specialists	Core		2021	2020
						E	E
Brought forward		funds	305,952				305,952	806,956
Income arising	in the year		3,080	104,245	71,929	26,565	205,819	136,455
Expenses paid	during the year		(64,322)	(104,245)	(71,929)	(26,565)	(267,061)	(637,459)
Carried forward		funds	244,710				244,710	305,952

.Analysis o	ffunds
			At 1April	Incoming	Resources	Gains	At 31
			2020	resources	expended	encl	March
						losses	2021
			E	E	E
Analysis of	movements	in funds
Unrestricted	fund		1,373,476	697,776	(460,188)	252,627	1,863,691
Restricted fund			305,952	205,819	(267,061)		244,710

		Fixed	Net	Non-	Total
		assets	current	current
			assets	creditors
				E	f
Unrestricted	fund	1,441,961	421,730		1,863,691
Restricted fund		896,679	(421,998)	(229,971)	244,710
		2,338,640	(268)	(229,971)	2,108,401

tially recognised at transaction value and subsequ	ently measured at their amortised cost.
Financial assets	2021	2020
Trade debtors
Other debtors	44,993	24,684
	44,993	24,684
Financial liabilities	2021	2020
Research grants	651,969	808,425
Other creditors	20,519	23,991
	672,488	832,416

Financial assets	2021	2020
	E
Investments	2,328,396	2,074,556